Boardroom Alpha
Boardroom Alpha
CNP · Additional Proxy Materials (DEFA14A) · Filed April 6, 2026

Centerpoint Energy Inc — Additional Proxy Materials (DEFA14A)

Form
DEFA14A
Filed
April 6, 2026
Ticker
CNP
Accession
0001104659-26-039732
Boardroom Alpha · Filing insights

CenterPoint Energy, Inc. urges a vote FOR Proposal 4 to add limited officer exculpation to its Charter.

About Centerpoint Energy Inc
Market cap
$27.3B
1Y TSR
+18.3%
3Y TSR
+16.4%
Board grade
B-
Sector
Utilities
CEO
Jason P Wells
Last annual meeting: Apr 16, 2026 · View full Centerpoint Energy Inc profile →

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 14A

 

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934
(Amendment No. )

 

Filed by the Registrant x

 

Filed by a party other than the Registrant ¨

 

Check the appropriate box:

 

¨ Preliminary Proxy Statement
   
¨ Confidential, for Use of the Commission Only (as Permitted by Rule 14a-6(e)(2))
   
¨ Definitive Proxy Statement
   
x Definitive Additional Materials
   
¨ Soliciting Material under § 240.14a-12

 

CenterPoint Energy, Inc.

(Name of Registrant as Specified in its Charter)

 (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

 

Payment of Filing Fee (Check all boxes that apply):

 

No fee required
   
Fee paid previously with preliminary materials
   
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

 

 

 

 

 

 

On April 6, 2026, CenterPoint Energy, Inc. issued the following communication to its shareholders:

 

 

 

Dear Valued Shareholder:

 

On March 4, 2026, we filed our definitive proxy statement for the CenterPoint Energy, Inc. (“CenterPoint or the Company”) 2026 Annual Meeting of Shareholders, scheduled for April 16, 2026. In the proxy statement, our Board of Directors (the “Board”) unanimously recommends a vote FOR Proposal 4 to add a limited officer exculpation provision to CenterPoint’s Articles of Incorporation (as amended and restated, the “Charter”) and to make certain other immaterial updates. This is a narrowly tailored, common-sense update designed to address an imbalance between the treatment of directors and officers for a limited category of claims that was carefully crafted by our Corporate Governance and Nominating Committee to align with widely accepted practice while preserving accountability.

 

What is limited officer exculpation?

 

·Like most public companies, we have a provision in our Charter eliminating the personal liability of our directors for monetary damages for breach of the fiduciary duty of care. This is what is referred to as “exculpation.”

 

·A recent amendment to Texas corporate law now allows a Texas corporation (like CenterPoint) to include a similar provision in its charter to exculpate officers for monetary damages for breach of the fiduciary duty of care in certain limited circumstances.

 

·Delaware adopted similar provisions in its corporate law effective in August 2022, and according to Deal Point Data, since that time shareholders have approved officer exculpation charter provisions at over 650 Delaware public companies.

 

·Like the existing director exculpation provision, the limited officer exculpation provision we are proposing would not exculpate officers from liability for breach of the duty of loyalty to the Company or its shareholders, acts or omissions not in good faith that constitute a breach of duty to the Company or that involve intentional misconduct or a knowing violation of law, any transaction in which the officer received an improper benefit, or an act or omission for which the liability of the officer is expressly provided by an applicable statute.

 

·The Board also carefully crafted the limited officer exculpation provision so as not to apply to derivative claims – this approach is actually more limited than what Texas law permits, and is aligned with the familiar officer exculpation framework under Delaware law.

 

Why is this important?

 

·The Board believes limited officer exculpation strikes a balance between the interest in officer accountability and the Company’s ability to attract and retain highly qualified officers, addresses inconsistent treatment between officers and directors, and can decrease the Company’s future litigation and insurance costs.

 

·Without an officer exculpation protection, individuals may be deterred from serving as officers due to exposure to personal liability and the risk of incurring substantial expense in defending lawsuits, regardless of merit. As noted above, over 650 public companies have recently adopted exculpation clauses that limit the personal liability of officers in their charters, and the Company expects that more public companies, including certain of the Company’s peers, will do so in the near future. The Board believes that failing to adopt the limited officer exculpation provision could therefore impact the Company’s recruitment and retention of exceptional officer candidates.

 

 

 

 

·In recent years, plaintiffs have employed the tactic of bringing certain claims against officers that would otherwise be exculpated if brought against directors to avoid dismissal of such claims, extract settlement leverage, and/or increase settlement value. The Board believes that the limited officer exculpation provision can address inconsistent treatment between officers and directors and reduce future litigation and insurance costs.

 

·Aligning the protections available to our officers with those available to our directors (with the exception of any derivative claims made by shareholders on behalf of the Company, for which exculpation for officers would be prohibited even though Texas law allows for such additional protection) would empower officers to better exercise their business judgment in furtherance of shareholder interests by limiting the potential for distraction posed by the risk of personal liability.

 

The Board of Directors unanimously believes Proposal 4 is in the best interests of CenterPoint Energy and its shareholders. It is a measured, responsible update that supports accountability, talent, and long-term value.

 

For all the above reasons, we ask you to vote FOR Proposal 4.

 

As always, we thank you for supporting CenterPoint.

 

CenterPoint Energy, Inc.

 

If you have any questions or need assistance in voting

your shares, please contact CenterPoint’s proxy solicitor, Okapi Partners, LLC, toll-free at (877) 796-5274 or via email at info@okapipartners.com

 

 

 

From this filing to the vote

Forecast every director vote the day the proxy files.

Meeting Forecast scores each director up for re-election + every contested situation, rebuilt daily across 6,000+ U.S. public companies. The same model that called the LULU contested proxy lives on every meeting you see here.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Centerpoint Energy Inc (CNP)

Reference

Frequently asked questions

When did Centerpoint Energy Inc file this DEFA14A?
Centerpoint Energy Inc (CNP) filed this Additional Proxy Materials (DEFA14A) with the SEC on April 6, 2026. The accession number assigned by EDGAR is 0001104659-26-039732.
What does a DEFA14A disclose?
DEFA14A is additional definitive proxy soliciting material filed in connection with a shareholder meeting — supplemental letters, slides, or amendments issued after the main proxy statement.
What is the key takeaway from this filing?
CenterPoint Energy, Inc. urges a vote FOR Proposal 4 to add limited officer exculpation to its Charter. This is Boardroom Alpha's one-line summary of the additional proxy materials; see the full filing text above for the formal disclosure.
Where can I find Centerpoint Energy Inc's prior proxy statements on EDGAR?
The SEC EDGAR browser lists every DEFA14A Centerpoint Energy Inc has filed under CIK 1130310, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer